Publication | Closed Access

The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg

Viral ReplicationMolecular VirologyHuman Papillomavirus VaccinesNuclear FormsMedicineMolecular BiologyVirologyHigh-risk Hpv E6Cell BiologyViral GeneticsViral OncologyCancer-associated Virus